Close
Nordic 9Nordic 9

UPMC Enterprises (investor - Corporate Investor)

United States enterprises.upmc.com
See something wrong or missing? Let us know
Offices:Pittsburgh

UPMC Enterprises is the venture capital arm of UPMC, a $26 billion health care provider and insurer based in Pittsburgh, USA

Average round investment:67.59M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)2023 (1)
Portfolio companies: United Kingdom UltromicsSwitzerland Noema Pharma
Mostly invests in: Switzerland Switzerland (2) Health services (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to UPMC Enterprises

Name Criteria
United States Polaris Partners
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Abingworth
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Concord Health Partners
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States PEAK6 Investments
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Mission BioCapital
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States venBio Partners
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States What If Ventures
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Foresite Capital
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Viking Global Investors
72%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Switzerland Julius Bär Group
72%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top